The clinical effectiveness and cost-effectiveness of topotecan for small cell lung cancer: a systematic review and economic evaluation

Objectives: To assess the clinical effectiveness and cost-effectiveness of topotecan as second-line treatment for small cell lung cancer (SCLC). Data sources: Bibliographic databases were searched from 1990 to February 2009, including the Cochrane library, MEDLINE (Ovid), EMBASE (Ovid), PREMEDLINE...

Full description

Bibliographic Details
Main Authors: Loveman, Emma (Author), Jones, Jeremy (Author), Hartwell, Debbie (Author), Bird, Alex (Author), Harris, Petra (Author), Welch, Karen (Author), Clegg, Andrew (Author)
Format: Article
Language:English
Published: 2010-03.
Subjects:
Online Access:Get fulltext
Get fulltext